Pregabalin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-618 -
Package NDC
71610-618-30 -
Package NDC
71610-618-46 -
Package NDC
71610-618-53 -
Package NDC
71610-618-54 -
Package NDC
71610-618-70 -
Application number
ANDA208677 -
SPL ID
d2de5bd4-13ac-4b83-8fa2-a75513e408fc -
SPL set ID
aa55a53c-96f6-4e0a-8b1d-e9d36e6ef2ec -
UNII
55JG375S6M -
RxCUI
483440 -
RxCUI
483448
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- PREGABALIN
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Pregabalin",
"splId": "d2de5bd4-13ac-4b83-8fa2-a75513e408fc",
"labels": [
{
"setId": "aa55a53c-96f6-4e0a-8b1d-e9d36e6ef2ec",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa55a53c-96f6-4e0a-8b1d-e9d36e6ef2ec",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa55a53c-96f6-4e0a-8b1d-e9d36e6ef2ec"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (71610-618-30)",
"package_ndc": "71610-618-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20220531"
},
{
"sample": false,
"description": "56 CAPSULE in 1 BOTTLE (71610-618-46)",
"package_ndc": "71610-618-46",
"identifierStatus": "well-formed",
"marketing_start_date": "20220531"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (71610-618-53)",
"package_ndc": "71610-618-53",
"identifierStatus": "well-formed",
"marketing_start_date": "20211202"
},
{
"sample": false,
"description": "84 CAPSULE in 1 BOTTLE (71610-618-54)",
"package_ndc": "71610-618-54",
"identifierStatus": "well-formed",
"marketing_start_date": "20240716"
},
{
"sample": false,
"description": "120 CAPSULE in 1 BOTTLE (71610-618-70)",
"package_ndc": "71610-618-70",
"identifierStatus": "well-formed",
"marketing_start_date": "20220531"
}
],
"productId": "71610-618_d2de5bd4-13ac-4b83-8fa2-a75513e408fc",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "71610-618",
"deaSchedule": "CV",
"genericName": "PREGABALIN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PREGABALIN",
"strength": "150 mg/1"
}
],
"applicationNumber": "ANDA208677",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190719",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"55JG375S6M"
],
"rxcui": [
"483440",
"483448"
],
"spl_set_id": [
"aa55a53c-96f6-4e0a-8b1d-e9d36e6ef2ec"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-618_d2de5bd4-13ac-4b83-8fa2-a75513e408fc"